The Lancet Infectious Diseases

A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new study published in The Lancet Infectious Diseases....

First comprehensive estimates from mainland China of the proportion of people with COVID-19 who required hospitalisation, and latest death rate estimates, both show sharp increases with age. Authors warn that without intervention the number of people...

Adding ‘repurposed’ antiparasitic drug to community-wide campaigns with antimalarial treatment could boost impact by up to 61%. A drug commonly used to treat parasitic diseases reveals further potential as a new tool for malaria control. A...

News Hour: Some strains of gonorrhea are now resistant to all available drugs, making vaccine development an urgent global health priority Exposure to the meningococcal group B vaccine during a New Zealand mass vaccination campaign was...

News Hour: The number of child deaths caused by diarrhoea reduced by a third between 2005-2015, but mortality rates remain highest in some of the world’s poorest countries, with diarrhoea killing almost half a million children...

News Hour: Cases of drug-resistant tuberculosis are forecasted to increase in the four high-burden countries (India, the Philippines, Russia, and South Africa) between 2000 and 2040, with the upturn likely to be a result of increased...

News Hour: The mcr-1 gene—a gene that makes bacteria resistant to colistin, an antibiotic of last resort, and that is transferrable between bacteria—has been found in a wide variety of strains of Escherichia coli in China...